Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.

Martínez-Lapiscina EH, Fraga-Pumar E, Gabilondo I, Martínez-Heras E, Torres-Torres R, Ortiz-Pérez S, Llufriu S, Tercero A, Andorra M, Roca MF, Lampert E, Zubizarreta I, Saiz A, Sanchez-Dalmau B, Villoslada P.

BMC Res Notes. 2014 Dec 15;7:910. doi: 10.1186/1756-0500-7-910.

2.

The King-Devick (K-D) test of rapid eye movements: a bedside correlate of disability and quality of life in MS.

Moster S, Wilson JA, Galetta SL, Balcer LJ.

J Neurol Sci. 2014 Aug 15;343(1-2):105-9. doi: 10.1016/j.jns.2014.05.047. Epub 2014 Jun 2.

PMID:
24954088
3.

Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study.

Galetta KM, Graves J, Talman LS, Lile DJ, Frohman EM, Calabresi PA, Galetta SL, Balcer LJ.

J Neuroophthalmol. 2012 Jun;32(2):116-23. doi: 10.1097/WNO.0b013e318240204d.

4.

Ganglion cell loss in relation to visual disability in multiple sclerosis.

Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, Henderson SB, Wilson JA, Maguire MG, Galetta SL, Frohman E, Calabresi PA, Schuman JS, Balcer LJ.

Ophthalmology. 2012 Jun;119(6):1250-7. doi: 10.1016/j.ophtha.2011.11.032. Epub 2012 Feb 23.

5.

Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.

Schinzel J, Zimmermann H, Paul F, Ruprecht K, Hahn K, Brandt AU, Dörr J.

BMC Neurol. 2014 Feb 20;14:31. doi: 10.1186/1471-2377-14-31.

6.

Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.

Gundogan FC, Tas A, Altun S, Oz O, Erdem U, Sobaci G.

Indian J Ophthalmol. 2013 Mar;61(3):100-3. doi: 10.4103/0301-4738.99842.

7.

Visual field impairment captures disease burden in multiple sclerosis.

Ortiz-Perez S, Andorra M, Sanchez-Dalmau B, Torres-Torres R, Calbet D, Lampert EJ, Alba-Arbalat S, Guerrero-Zamora AM, Zubizarreta I, Sola-Valls N, Llufriu S, Sepúlveda M, Saiz A, Villoslada P, Martinez-Lapiscina EH.

J Neurol. 2016 Apr;263(4):695-702. doi: 10.1007/s00415-016-8034-2. Epub 2016 Feb 9.

PMID:
26860093
8.

Utility of the National Eye Institute VFQ-25 questionnaire in a heterogeneous group of multiple sclerosis patients.

Noble J, Forooghian F, Sproule M, Westall C, O'Connor P.

Am J Ophthalmol. 2006 Sep;142(3):464-8.

PMID:
16935592
9.

Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.

Blanco R, Pérez-Rico C, Puertas-Muñoz I, Ayuso-Peralta L, Boquete L, Arévalo-Serrano J.

Mult Scler. 2014 Feb;20(2):183-91. doi: 10.1177/1352458513493683. Epub 2013 Jul 4.

PMID:
23828868
10.

Color vision is strongly associated with retinal thinning in multiple sclerosis.

Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A.

Mult Scler. 2012 Jul;18(7):991-9. doi: 10.1177/1352458511431972. Epub 2012 Jan 30.

PMID:
22291035
11.

Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis.

Chahin S, Miller D, Sakai RE, Wilson JA, Frohman T, Markowitz C, Jacobs D, Green A, Calabresi PA, Frohman EM, Galetta SL, Balcer LJ.

Mult Scler Relat Disord. 2015 Jul;4(4):304-10. doi: 10.1016/j.msard.2015.05.005. Epub 2015 May 21.

PMID:
26195047
12.

Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.

Laron M, Cheng H, Zhang B, Schiffman JS, Tang RA, Frishman LJ.

Mult Scler. 2010 Apr;16(4):412-26. doi: 10.1177/1352458509359782. Epub 2010 Mar 5.

13.

Sight-dependent quality of life and ophthalmic findings in a group of Brazilian patients with multiple sclerosis.

Fragoso YD, Nosé RM, Nosé RA, Nosé W, Vieira S, Finkelsztejn A.

Arq Neuropsiquiatr. 2011 Oct;69(5):809-13.

14.

Electropysiologic evaluation of the visual pathway in patients with multiple sclerosis.

Rodriguez-Mena D, Almarcegui C, Dolz I, Herrero R, Bambo MP, Fernandez J, Pablo LE, Garcia-Martin E.

J Clin Neurophysiol. 2013 Aug;30(4):376-81. doi: 10.1097/WNP.0b013e31829d75f7.

PMID:
23912576
15.

Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients.

Sriram P, Wang C, Yiannikas C, Garrick R, Barnett M, Parratt J, Graham SL, Arvind H, Klistorner A.

PLoS One. 2014 Aug 28;9(8):e102546. doi: 10.1371/journal.pone.0102546. eCollection 2014.

16.

Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.

Jasse L, Vukusic S, Durand-Dubief F, Vartin C, Piras C, Bernard M, Pélisson D, Confavreux C, Vighetto A, Tilikete C.

Mult Scler. 2013 Oct;19(12):1618-26. doi: 10.1177/1352458513479840. Epub 2013 Mar 5.

PMID:
23462348
17.

Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations.

Serbecic N, Aboul-Enein F, Beutelspacher SC, Graf M, Kircher K, Geitzenauer W, Brannath W, Lang P, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U.

PLoS One. 2010 Nov 8;5(11):e13877. doi: 10.1371/journal.pone.0013877.

18.

Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients.

Pérez-Rico C, Ayuso-Peralta L, Rubio-Pérez L, Roldán-Díaz I, Arévalo-Serrano J, Jiménez-Jurado D, Blanco R.

Invest Ophthalmol Vis Sci. 2014 Sep 4;55(10):6127-31. doi: 10.1167/iovs.14-14807.

PMID:
25190654
19.

The visual pathway as a model to understand brain damage in multiple sclerosis.

Martínez-Lapiscina EH, Sanchez-Dalmau B, Fraga-Pumar E, Ortiz-Perez S, Tercero-Uribe AI, Torres-Torres R, Villoslada P.

Mult Scler. 2014 Nov;20(13):1678-85. doi: 10.1177/1352458514542862. Epub 2014 Jul 10. Review.

PMID:
25013155
20.

Relationships Between Measures of the Ability to Perform Vision-Related Activities, Vision-Related Quality of Life, and Clinical Findings in Patients With Glaucoma.

Ekici F, Loh R, Waisbourd M, Sun Y, Martinez P, Nayak N, Wizov SS, Hegarty S, Hark LA, Spaeth GL.

JAMA Ophthalmol. 2015 Dec;133(12):1377-85. doi: 10.1001/jamaophthalmol.2015.3426.

PMID:
26425961

Supplemental Content

Support Center